Hebron® was founded in 1990 with the objective of producing pharmaceutical products using two great national resources: raw material, stemming from our natural resources, and the scientific and technological potential available at Brazilian Universities and Research Institutes.

Hebron’s creation introduced a new mindset in Brazil. It showed the importance of biodiversity for the production of medicines and for the development of products, in association with Brazilian Research Institutes and Universities.

Monthly, 38,410 doctors are visited by our advertising representatives, in 950 cities in Brazil. Hebron’s medicines are present in 1,873 cities in the country. Hebron operates in the foreign market with a subsidiary in Peru and exports to three additional countries.

The Company carries 135 pharmaceutical products in 13 medical specialties, with Pediatrics, Internal Medicine, Gynecology and Cardiology standing out.

Product Research and Development

It is developing a project in England and keeps close relationship with Universidade de Farmácia do Porto – Portugal.
It has already interacted with other large centers, among them one of the largest phytochemistry research centers in the world, in Lausanne, Switzerland, and with the New York Hospital, where one of its medicines is undergoing preliminary tests.